Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial (Q38490930)
Jump to navigation
Jump to search
scientific article published on 16 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial |
scientific article published on 16 May 2011 |
Statements
1 reference
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial (English)
1 reference
Lars Wallentin
1 reference
Hans-Christoph Diener
1 reference
Salim Yusuf
1 reference
Jonas Oldgren
1 reference
Stefan H Hohnloser
1 reference
Paul Reilly
1 reference
Marco Alings
1 reference
Jeanne Varrone
1 reference
Maria Grazia Franzosi
1 reference
Sean Yang
1 reference
Mike Ezekowitz
1 reference
Scott Kaatz
1 reference
Stuart J Connolly
1 reference
Jeff S Healey
1 reference
Kurt Huber
1 reference
16 May 2011
1 reference
1 reference
Identifiers
1 reference